Thompson Siegel & Walmsley LLC Eton Pharmaceuticals, Inc. Transaction History
Thompson Siegel & Walmsley LLC
- $6.71 Billion
- Q3 2024
A detailed history of Thompson Siegel & Walmsley LLC transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Thompson Siegel & Walmsley LLC holds 115,030 shares of ETON stock, worth $1.47 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
115,030
Previous 127,724
9.94%
Holding current value
$1.47 Million
Previous $420,000
64.29%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ETON
# of Institutions
51Shares Held
9.44MCall Options Held
261KPut Options Held
500-
Opaleye Management Inc. Boston, MA2.78MShares$35.4 Million3.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.03MShares$13.1 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT999KShares$12.7 Million0.36% of portfolio
-
Westside Investment Management, Inc.619KShares$7.88 Million0.79% of portfolio
-
Acuitas Investments, LLC580KShares$7.39 Million1.66% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $322M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...